X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adolescent (4) 4
female (4) 4
humans (4) 4
child (3) 3
child, preschool (3) 3
children (3) 3
hematology (3) 3
imatinib (3) 3
index medicus (3) 3
male (3) 3
antineoplastic agents (2) 2
chronic myelogenous leukemia (2) 2
chronic myeloid leukemia (2) 2
chronic phase (2) 2
cml (2) 2
disease-free survival (2) 2
early molecular response (2) 2
italy (2) 2
leukemia, myelogenous, chronic, bcr-abl positive - mortality (2) 2
trial (2) 2
tyrosine kinase inhibitors (2) 2
1450-1455 (1) 1
800 mg (1) 1
acalculous cholecystitis - complications (1) 1
acalculous cholecystitis - virology (1) 1
acute acalculous (1) 1
acute acalculous cholecystitis (1) 1
adolescence (1) 1
adolescents (1) 1
adult (1) 1
age factors (1) 1
antimitotic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
association (1) 1
bcr-abl1 (1) 1
bcr-abl1 transcript levels (1) 1
bcr‐abl1 (1) 1
benzamides (1) 1
benzamides - administration & dosage (1) 1
biomarkers, tumor - blood (1) 1
blood lymphocyte/monocyte ratio (1) 1
blood platelets (1) 1
cancer research (1) 1
childhood (1) 1
childhood leukaemia (1) 1
childhood leukaemia; cml; early response; outcome; tyrosine kinase inhibitors; adolescent; child; child, preschool; female; humans; imatinib mesylate; leukemia, myelogenous, chronic, bcr-abl positive; male; hematology (1) 1
childhood leukemia (1) 1
cholecystitis (1) 1
cholestasis (1) 1
chotecystitis (1) 1
chronic myeloid leukaemia (1) 1
cml patients (1) 1
cml; childhood leukaemia; early response; outcome; tyrosine kinase inhibitors (1) 1
databases, factual (1) 1
diagnosis (1) 1
discontinuation (1) 1
disease (1) 1
disease progression (1) 1
dosage and administration (1) 1
early interim (1) 1
early response (1) 1
eosinophilia (1) 1
eosinophils (1) 1
epstein-barr virus (1) 1
epstein-barr virus infections - complications (1) 1
epstein–barr virus (1) 1
europe (1) 1
ferritins - blood (1) 1
follow-up (1) 1
follow-up studies (1) 1
fusion proteins, bcr-abl (1) 1
fusion proteins, bcr-abl - genetics (1) 1
gallbladder (1) 1
geschichte (1) 1
geschichte des hochschulwesens (1) 1
gonads (1) 1
health aspects (1) 1
hematology, oncology and palliative medicine (1) 1
hemic and lymphatic diseases (1) 1
hepatitis (1) 1
history (1) 1
hodgkin disease - blood (1) 1
hodgkin disease - diagnosis (1) 1
hodgkin disease - drug therapy (1) 1
hodgkin disease - mortality (1) 1
hodgkin disease - pathology (1) 1
hodgkin lymphoma (1) 1
identification (1) 1
imatinib discontinuation (1) 1
imatinib mesylate (1) 1
imatinib mesylate - administration & dosage (1) 1
infant (1) 1
infant, newborn (1) 1
infectious disease (1) 1
infectious diseases (1) 1
infectious mononucleosis (1) 1
infectious-diseases (1) 1
inflammation (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 5301 - 5301
Abstract Metastatic disease of the bone is a rare complication of chronic lymphocytic leukemia (CLL), it may be result from richter's transformation or... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3083 - 3083
Abstract Before 2000, allogeneic hematopoietic stem cell transplantation (HSCT) was the only potentially curative treatment for children with chronic myeloid... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2015, Volume 170, Issue 3, pp. 398 - 407
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2788 - 2788
Abstract Reports in adults have shown that a BCR-ABL1 IS <10% at 3 months after the start of imatinib (IM) can predict better clinical outcome in chronic... 
Journal Article
Acta Haematologica, ISSN 0001-5792, 10/2018, Volume 140, Issue 2, pp. 105 - 111
Background: To date, no data on the adherence to specific guidelines for children with chronic myeloid leukemia (CML) in chronic phase (CP) have been reported.... 
Childhood leukemia | Tyrosine kinases | Imatinib | Chronic myeloid leukemia | CHRONIC MYELOGENOUS LEUKEMIA | CHRONIC PHASE | CML | IMATINIB DISCONTINUATION | EUROPE | POLYMERASE-CHAIN-REACTION | RECOMMENDATIONS | RESIDUAL DISEASE DETECTION | HEMATOLOGY | ASSOCIATION | REMISSION
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1812 - 1812
Abstract Imatinib (IM) is an established first-line treatment for children with chronic myeloid leukemia (CML). However, the most effective dosage of IM and... 
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 52, pp. 33 - 40
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 1490 - 1490
Abstract Imatinib (IM) is an established first-line treatment for children with chronic myeloid leukemia (CML). However, the most effective dosage and duration... 
Journal Article
Blood, ISSN 0006-4971, 11/2006, Volume 108, Issue 11, pp. 3595 - 3595
Abstract There is a high prevalence of thromboembolic events in myeloproliferative syndromes (MPS) ranging from 20% to 40% as compared to the general elderly... 
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 2725 - 12
Disease is an increasing threat for marine bivalves worldwide. Recently, a mass mortality event (MME) impacting the bivalve Pinna nobilis was detected across a... 
ORGANISMS | PARASITES | LYSOSOMES | INFECTIOUS-DISEASES | TUBERCULOSIS | MULTIDISCIPLINARY SCIENCES | SP-NOV | PATHOLOGY | IDENTIFICATION | PCR-BASED DETECTION | SHERRISII | Shells | Inflammation | Gonads | Mortality
Journal Article
1994, Fonti e studi per la storia dell'Università di Pavia, ISBN 8832346206, Volume 21, 38, 58, v.
Book
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.